-DOCSTART- -X- O
Vaccines -X- _ O
have -X- _ O
shown -X- _ O
great -X- _ O
success -X- _ O
in -X- _ O
treating -X- _ O
and -X- _ O
preventing -X- _ O
tumors -X- _ O
and -X- _ O
infections -X- _ O
, -X- _ O
while -X- _ O
adjuvants -X- _ O
are -X- _ O
always -X- _ O
demanded -X- _ O
to -X- _ O
ensure -X- _ O
potent -X- _ O
immune -X- _ O
responses. -X- _ O
Polyethylenimine -X- _ B-Intervention
( -X- _ I-Intervention
PEI -X- _ I-Intervention
) -X- _ I-Intervention
, -X- _ O
as -X- _ O
one -X- _ O
of -X- _ O
the -X- _ O
well-studied -X- _ O
cationic -X- _ O
polymers -X- _ O
, -X- _ O
has -X- _ O
been -X- _ O
used -X- _ O
as -X- _ O
a -X- _ O
transfection -X- _ O
reagent -X- _ O
for -X- _ O
decades. -X- _ O
However -X- _ O
, -X- _ O
increasing -X- _ O
evidence -X- _ O
has -X- _ O
shown -X- _ O
that -X- _ O
PEI-based -X- _ B-Intervention
particles -X- _ I-Intervention
are -X- _ O
also -X- _ O
capable -X- _ O
of -X- _ O
acting -X- _ O
as -X- _ O
adjuvants. -X- _ O
In -X- _ O
this -X- _ O
paper -X- _ O
, -X- _ O
we -X- _ O
briefly -X- _ O
review -X- _ O
the -X- _ O
physicochemical -X- _ O
properties -X- _ O
and -X- _ O
the -X- _ O
broad -X- _ O
applications -X- _ O
of -X- _ O
PEI -X- _ O
in -X- _ O
different -X- _ O
fields -X- _ O
, -X- _ O
and -X- _ O
elaborate -X- _ O
on -X- _ O
the -X- _ O
intracellular -X- _ B-Outcome
processes -X- _ I-Outcome
of -X- _ I-Outcome
PEI-based -X- _ I-Outcome
vaccines. -X- _ I-Outcome
In -X- _ O
addition -X- _ O
, -X- _ O
we -X- _ O
sum -X- _ O
up -X- _ O
the -X- _ O
proof -X- _ B-Outcome
of -X- _ I-Outcome
their -X- _ I-Outcome
in -X- _ I-Outcome
vivo -X- _ I-Outcome
and -X- _ I-Outcome
clinical -X- _ I-Outcome
applications. -X- _ I-Outcome
We -X- _ O
also -X- _ O
highlight -X- _ O
some -X- _ O
mechanisms -X- _ O
proposed -X- _ O
for -X- _ O
the -X- _ O
intrinsic -X- _ O
immunoactivation -X- _ O
function -X- _ O
of -X- _ O
PEI -X- _ O
, -X- _ O
followed -X- _ O
by -X- _ O
the -X- _ B-Outcome
challenges -X- _ I-Outcome
and -X- _ I-Outcome
future -X- _ I-Outcome
perspectives -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
applications -X- _ I-Outcome
of -X- _ I-Outcome
PEI -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
vaccines -X- _ I-Outcome
, -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
some -X- _ B-Outcome
strategies -X- _ I-Outcome
to -X- _ I-Outcome
elicit -X- _ I-Outcome
the -X- _ I-Outcome
desirable -X- _ I-Outcome
immune -X- _ I-Outcome
responses -X- _ I-Outcome
. -X- _ O

